化合物简介
Copanlisib (BAY 80-6946), developed by Bayer, is a selective Class I phosphoinositide 3-kinase inhibitor which has shown promise in Phase I/II clinical trials for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
基本信息
中文名称
Copanlisib
英文名称
2-amino-N-[7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1 ,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide
中文别名
英文别名
BAY 80-6946、2-Amino-N.N-diaethyl-toluolsulfonamid-(4)、2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide、2-amino-toluene-4-sulfonic acid diethylamide、2-Amino-toluol-4-sulfonsaeure-diaethylamid
CAS号
1032568-63-0
分子式
C23H28N8O4
分子量
480.52
精确质量
480.223
PSA
146.23
LOGP
0.3724
